The report presents the results of the zoonoses monitoring activities carried out in 2013 in 32 European countries:eg 28 Member States (MS) and four non-Member States (non-MS) European Free Trade Association (EFTA) countries.
The goal of this systematic review is to update the 2011 ECDC risk assessment. Evidence from this review will be used to develop guidance on this topic.
This systematic review seeks to identify evidence for the effectiveness of targeted infection control measures to control the spread and transmission of ESBL-E when transferring patients between healthcare settings, especially when the transfer is cross-border.
From 21 to 28 November 2014, nearly 700 organisations across Europe will host activities to increase awareness of the personal and public health benefits of HIV testing. As HIV infection can remain asymptomatic for a long time and a substantial number of infected persons across Europe are unaware of their infection, ECDC supports the aims of this second European HIV testing week.
ECDC gathered guidance documents on prevention and control of infection with carbapenem-resistant Enterobacteriaceae (CRE) available online, published by EU/EEA Member States, ECDC, other agencies and scientific societies.
Monitoring and responding to HIV and hepatitis C among people who inject drugs is the focus of two new reports from the EU drugs agencies EMCDDA and ECDC.
This report presents the results of the first external quality assurance (EQA) scheme for Bordetella identification and typing funded by the European Centre for Disease Prevention and Control (ECDC).
This report presents the results of an external quality assurance (EQA) scheme for Bordetella pertussis serology which was carried out during the summer of 2013.